One novel line of research has investigated the potential to enhance mechanisms of learning during cognitive behavioral therapies (such as those used for PTSD) by administering medications that could facilitate fear extinction, for example, d-cycloserine, yohimbine, methylene blue, MDMA, and oxytocin [93,94]. This evidence concerns the gene OXT and post-traumatic stress disorder.